A Phase I, Blinded, Randomized Study of Nebulized RNS60 Combination With Budesonide in Adult Healthy Subjects and Patients With Mild to Moderate Chronic Asthma.
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2014
At a glance
- Drugs RNS 60 (Primary) ; Budesonide
- Indications Asthma
- Focus Adverse reactions
- 04 Mar 2014 Results presented at the 70th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 11 Jan 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 11 Jan 2012 Actual patient number is 36 according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History